1. Morphologic changes following therapy;Abeloff,1981
2. Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581) an Eastern Cooperative Oncology Group Study;Abeloff;Cancer Treat. Rep.,1985
3. Phase II trials of α-Difluoromethylornithine (DFMO) an inhibitor of polyamine synthesis, in advanced small cell lung cancer (SCLC) and colon cancer (CC);Abeloff,1985
4. Role of chemotherapy in small cell lung cancer: A consensus report of the Study of Lung Cancer Workshop;Aisner;Cancer Treat. Rep.,1983
5. Lonidamine (LDM), a new anticancer agent: overview of Canadian trials;Band,1984